Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Chimerix CMX001 a new promising antiviral used successfully for CMV and maybe CFS/ME

Discussion in 'General ME/CFS News' started by LHCTom, Mar 24, 2012.

  1. LHCTom

    LHCTom

    Messages:
    65
    Likes:
    51
    vli likes this.
  2. gu3vara

    gu3vara Senior Member

    Messages:
    339
    Likes:
    49
    Yesm, Cort wrote an article about it a couple months ago. Seems really promising. Less toxic than Vistide and going deeper in the tissues.
     
  3. August59

    August59 Daughters High School Graduation

    Messages:
    1,617
    Likes:
    615
    Upstate SC, USA
    I think the last thing I saw and I believe it was the article Cort had authored which did not give much faith in the company testing it for CFS/ME. They seem to be strictly targeting CMV in transplant patients. I could very well be wrong and please keep looking for a definitive answer, but this is sticking in my mind for some reason.
     
  4. Sparrowhawk

    Sparrowhawk Senior Member

    Messages:
    487
    Likes:
    270
    West Coast USA
    Any update on CMX001?
     
    heapsreal likes this.

See more popular forum discussions.

Share This Page